Marshall Wace North America’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $18M | Buy |
|
|||||
|
2021
Q2 | $617K | Sell |
|
|||||
|
2021
Q1 | $22.8M | Sell |
|
|||||
|
2020
Q4 | $44.7M | Buy |
|
|||||
|
2020
Q3 | $32.6M | Buy |
|
|||||
|
2020
Q2 | $22.3M | Sell |
|
|||||
|
2020
Q1 | $20.4M | Sell |
|
|||||
|
2019
Q4 | $65.6M | Sell |
|
|||||
|
2019
Q3 | $79.8M | Sell |
|
|||||
|
2019
Q2 | $101M | Sell |
|
|||||
|
2019
Q1 | $137M | Buy |
|
|||||
|
2018
Q4 | $46.5M | Buy |
|
|||||
|
2018
Q3 | $49.8M | Buy |
|
|||||
|
2018
Q2 | $42.5M | Buy |
|
|||||
|
2018
Q1 | $37.5M | Buy |
|
|||||
|
2017
Q4 | $14.7M | Sell |
|
|||||
|
2017
Q3 | $16.4M | Buy |
|
|||||
|
2017
Q2 | $4.88M | Sell |
|
|||||
|
2017
Q1 | $5.02M | Buy |
|